 |
 |
 |
Saw palmetto, dwarf palmetto
Serenoa repens (Bartram) Small; Synonym:
Sabal serrulata (Michaux) Nutall
ex Schultes
Arecaceae
Relief of symptoms of benign prostatic hypertrophy (BPH)
Relief of urination difficulties associated with BPH
160 mg, 2 X/day of a 10:1 standardized liposterolic berry extract containing 85-95% fatty acids and sterols. A minimum treatment time of 30 days is required for therapeutic benefits.
The lipophilic fraction containing fatty acids and sterols is considered the active fraction.
Well-designed clinical studies have established that saw palmetto extracts can provide relief from symptoms of BPH comparable to standard prescription medications. In addition to reducing symptoms of prostate enlargement, saw palmetto extract can alleviate urinary problems such as frequent urination, nocturia, painful urination, urinary tract infections, and bladder and urethral irritation. A minimum treatment time of 30 days is required for the therapeutic benefits to become apparent. Treatment can be continued for years without adverse side effects.
Carraro, J.C., Raynaud, J.P., Koch, G. et al. (1996). Comparison of phytotherapy (Permixon®) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients. Prostate 29: 231-240.
Braeckman, J., Denis, L., Laval, J. De et al. (1997). A double-blind, placebo-controlled study of the plant extract Serenoa repense in the treatment of benign hyperplasia of the prostate. European Journal of Clinical Research 9:247-259.
Witt, T.J., JIshani, A., Stark, G (1998). Saw palmetto extracts for treatment of benign prostatic hyperplasia. A systematic review. Journal of the American Medical Association 280:1604-1609
